Benjamin Hewitt in Dothan, Alabama

Home Alabama Dothan

Benjamin Hewitt has Gastroenterology as his primary medical specialty. Their primary office is: 265 Medical Park Boulevard in Dothan, Alabama. There is an additional office location, for a total of two, for Benjamin Hewitt that can be viewed further down.

They're a part of the: Gut Pc medical group which has around 40 members. You can call their office at 334-305-0112 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Alabama School Of Medicine and graduated in 2017 (around 7 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Benjamin Hewitt Office Phone and Directions

Benjamin Hewitt
Gut Pc
265 Medical Park Boulevard
Dothan, Alabama 36301
334-305-0112

Patient Ratings
Please rate your experience with Benjamin Hewitt below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 334-305-0112

Enter a starting address:

Healthcare Info for Benjamin Hewitt

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Alabama School Of Medicine
Graduation Year: 2017
The Primary Medical Specialty for Benjamin Hewitt is listed as: Gastroenterology
Approximate Years of Experience: 7
PAC (PECOS ID)#: 5799109294
NPI #: 1982145181
NPI Created On: 03/20/2017
NPI Last Updated Listed as: 07/26/2023
Primary Taxonomy Code: 207RG0100X
License Number:
11772330-1205
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $130

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783421389

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Neuroscience

Name of Drug #1: ZEPOSIA

Open Associated Drug #1: 59572-820-30